The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.20, FiscalAI reports. The firm had revenue of $114.44 million during the quarter, compared to analysts’ expectations of $111.01 million. GeneDx Stock PerformanceShares of NASDAQ WGS opened at $67.86 on Tuesday. In the last ninety days, insiders acquired 2,256,420 shares of company stock valued at $93,144,340 and sold 19,135 shares valued at $1,128,499. Finally, Cetera Investment Advisers purchased a new position in shares of GeneDx during the 2nd quarter valued at approximately $249,000.